People with HIV should participate in tuberculosis vaccine trials, new recommendations say

Experts say that people with HIV should be included in clinical trials for new tuberculosis vaccine candidates in the pipeline, according to newly written recommendations published in The Lancet HIV.
Recent WHO data show that TB leads to 1.5 million deaths in 2020, with nearly 10 million people developing TB that same year — 8% of whom were also infected with HIV. These data mean that almost 800,000 diagnosed cases that caused roughly 214,000 deaths were among people with HIV.
Further data showed that people living with HIV have a 15- to 21-fold greater likelihood of developing TB and

Experts say that people with HIV should be included in clinical trials for new tuberculosis vaccine candidates in the pipeline, according to newly written recommendations published in The Lancet HIV.
Recent WHO data show that TB leads to 1.5 million deaths in 2020, with nearly 10 million people developing TB that same year — 8% of whom were also infected with HIV. These data mean that almost 800,000 diagnosed cases that caused roughly 214,000 deaths were among people with HIV.
Further data showed that people living with HIV have a 15- to 21-fold greater likelihood of developing TB and